Sign in
Comparing Outcomes of Standard and Reduced-Fluence Photodynamic Therapy in the Treatment of Polypoidal Choroidal Vasculopathy
Colin S Tan, MBBS, MMed (Ophth), FRCSEd (Ophth)
Annual Meeting Talks
2018
New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases
Alay S. Banker, MD
Clinical Course and Outcomes at 3 Years After Severe Fungal Endophthalmitis in 14 Eyes Following Contaminated Bevacizumab Intravitreal Injection
Mallika Goyal, MD
Category: Retinal Vascular Disease